688278 特宝生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)23.95037.36633.82822.34616.765
总资产报酬率 ROA (%)19.48730.61526.92517.97213.848
投入资产回报率 ROIC (%)22.38035.66032.27721.40016.036

边际利润分析
销售毛利率 (%)92.55893.48693.33288.91688.948
营业利润率 (%)31.51334.45832.41026.65021.950
息税前利润/营业总收入 (%)29.38532.97130.27423.03718.918
净利润/营业总收入 (%)26.86529.37726.44618.79716.004

收益指标分析
经营活动净收益/利润总额(%)103.739100.511103.762101.885102.294
价值变动净收益/利润总额(%)0.5050.5300.9671.1013.151
营业外收支净额/利润总额(%)-6.893-4.265-6.254-14.328-15.441

偿债能力分析
流动比率 (X)3.8434.3443.3203.5674.708
速动比率 (X)3.1993.7172.8573.0834.051
资产负债率 (%)20.52116.29620.35920.46918.461
带息债务/全部投入资本 (%)5.3701.3441.194-2.475-2.488
股东权益/带息债务 (%)1,704.6487,125.5677,950.842-3,880.651-3,836.142
股东权益/负债合计 (%)387.298513.644391.173388.546441.687
利息保障倍数 (X)-306.003-426.964-132.170-84.160-196.146

营运能力分析
应收账款周转天数 (天)84.95777.26856.12547.56255.529
存货周转天数 (天)466.893441.944407.086261.874310.866